T. Jantararoungtong

发表

Strong association between HLA-B*5801 and allopurinol-induced Stevens–Johnson syndrome and toxic epidermal necrolysis in a Thai population

S. Tiamkao, W. Tassaneeyakul, T. Jantararoungtong, 2009, Pharmacogenetics and genomics.

Association between HLA‐B*1502 and carbamazepine‐induced severe cutaneous adverse drug reactions in a Thai population

S. Tiamkao, Shu‐Yi Lin, W. Tassaneeyakul, 2010, Epilepsia.

Association of HLA-A and HLA-B Alleles with Lamotrigine-Induced Cutaneous Adverse Drug Reactions in the Thai Population

C. Sukasem, W. Tassaneeyakul, U. Intusoma, 2017, Front. Pharmacol..

Dapsone-induced severe cutaneous adverse drug reactions are strongly linked with HLA-B*13: 01 allele in the Thai population

C. Sukasem, W. Tassaneeyakul, T. Jantararoungtong, 2017, Pharmacogenetics and genomics.

Association between HLA-B Alleles and Carbamazepine-Induced Maculopapular Exanthema and Severe Cutaneous Reactions in Thai Patients

W. Aekplakorn, C. Sukasem, T. Jantararoungtong, 2018, Journal of immunology research.

Development of Pyrosequencing Method for UGT 1 A 1 Polymorphisms in Thai Colorectal Cancer

C. Sukasem, T. Jantararoungtong, N. Koomdee, 2013 .

CYP2C19 polymorphisms in the Thai population and the clinical response to clopidogrel in patients with atherothrombotic-risk factors

C. Sukasem, T. Jantararoungtong, N. Koomdee, 2013, Pharmacogenomics and personalized medicine.

Associations between UGT1A1 and SLCO1B1 polymorphisms and susceptibility to neonatal hyperbilirubinemia in Thai population

C. Sukasem, T. Jantararoungtong, A. Puangpetch, 2022, BMC Pediatrics.

Pharmacogenomics research and its clinical implementation in Thailand: Lessons learned from the resource-limited settings.

C. Sukasem, T. Jantararoungtong, N. Koomdee, 2021, Drug metabolism and pharmacokinetics.

High plasma efavirenz concentration and CYP2B6 polymorphisms in Thai HIV-1 infections.

W. Chantratita, C. Sukasem, W. Manosuthi, 2013, Drug metabolism and pharmacokinetics.

TPMT*3C as a Predictor of 6-Mercaptopurine-Induced Myelotoxicity in Thai Children with Acute Lymphoblastic Leukemia

S. Pakakasama, C. Sukasem, T. Jantararoungtong, 2021, Journal of personalized medicine.

Influence of SULT1A1*2 Polymorphism on Plasma Efavirenz Concentration in Thai HIV-1 Patients

A. Gaedigk, C. Sukasem, W. Manosuthi, 2021, Pharmacogenomics and personalized medicine.

PGPM_A_306358 915..926

A. Gaedigk, C. Sukasem, W. Manosuthi, 2021 .

Development and Validation of Voriconazole Concentration by LC‐MS‐MS: Applied in Clinical Implementation

C. Sukasem, Nuttawut Jenjirattithigarn, T. Jantararoungtong, 2017, Journal of clinical laboratory analysis.

Pharmacogenetics and clinical biomarkers for subtherapeutic plasma efavirenz concentration in HIV-1 infected Thai adults.

C. Sukasem, W. Manosuthi, T. Jantararoungtong, 2014, Drug metabolism and pharmacokinetics.

Low level of efavirenz in HIV-1-infected Thai adults is associated with the CYP2B6 polymorphism

C. Sukasem, W. Manosuthi, T. Jantararoungtong, 2014, Infection.

HLA-B*13 :01 Is a Predictive Marker of Dapsone-Induced Severe Cutaneous Adverse Reactions in Thai Patients

M. Pirmohamed, T. Rungrotmongkol, D. Naisbitt, 2021, Frontiers in Immunology.

Genetic Diversity of HLA Class I and Class II Alleles in Thai Populations: Contribution to Genotype-Guided Therapeutics

W. Aekplakorn, Chumpol Ngamphiw, S. Tongsima, 2020, Frontiers in Pharmacology.

HLA-B*58:01 for Allopurinol-Induced Cutaneous Adverse Drug Reactions: Implication for Clinical Interpretation in Thailand

C. Sukasem, T. Jantararoungtong, N. Koomdee, 2016, Front. Pharmacol..

Pharmacogenetic markers of CYP2B6 associated with efavirenz plasma concentrations in HIV-1 infected Thai adults.

W. Chantratita, C. Sukasem, T. Jantararoungtong, 2012, British journal of clinical pharmacology.

Impact of CYP2C19, CYP3A4, ABCB1, and FMO3 genotypes on plasma voriconazole in Thai patients with invasive fungal infections

C. Sukasem, T. Jantararoungtong, A. Puangpetch, 2020, Pharmacology research & perspectives.

HLA-B allele and haplotype diversity among Thai patients identified by PCR-SSOP: evidence for high risk of drug-induced hypersensitivity

C. Sukasem, T. Jantararoungtong, N. Koomdee, 2015, Front. Genet..

Allele frequencies of single nucleotide polymorphisms of clinically important drug-metabolizing enzymes CYP2C9, CYP2C19, and CYP3A4 in a Thai population

C. Sukasem, T. Jantararoungtong, N. Koomdee, 2021, Scientific Reports.

A prospective observational study of CYP2C19 polymorphisms and voriconazole plasma level in adult Thai patients with invasive aspergillosis.

C. Sukasem, T. Jantararoungtong, A. Puangpetch, 2016, Drug metabolism and pharmacokinetics.

Evolution of HLA-B Pharmacogenomics and the Importance of PGx Data Integration in Health Care System: A 10 Years Retrospective Study in Thailand

C. Sukasem, M. Biswas, T. Jantararoungtong, 2022, Frontiers in Pharmacology.

HLA‐B*1502 Strongly Predicts Carbamazepine‐Induced Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis in Thai Patients with Neuropathic Pain

S. Tiamkao, W. Tassaneeyakul, T. Jantararoungtong, 2012, Pain practice : the official journal of World Institute of Pain.

Genotyping HLA alleles to predict the development of Severe cutaneous adverse drug reactions (SCARs): state-of-the-art

C. Sukasem, T. Jantararoungtong, N. Koomdee, 2021, Expert opinion on drug metabolism & toxicology.

Implementation of HLA-B*15:02 Genotyping as Standard-of-Care for Reducing Carbamazepine/Oxcarbazepine Induced Cutaneous Adverse Drug Reactions in Thailand

C. Sukasem, M. Biswas, T. Jantararoungtong, 2022, Frontiers in Pharmacology.

Spectrum of cutaneous adverse reactions to aromatic antiepileptic drugs and human leukocyte antigen genotypes in Thai patients and meta-analysis

W. Aekplakorn, T. Rungrotmongkol, C. Sukasem, 2021, The Pharmacogenomics Journal.

7th Drug hypersensitivity meeting: part two

S. Mallal, A. Borobia, P. Korošec, 2016, Clinical and Translational Allergy.